CATALYST BIOSCIENCES INC (CBIO)       0.295  -0.01 (-2.99%)

0.295  -0.01 (-2.99%)

US14888D2080 - Common Stock - After market: 0.3 +0.01 (+1.69%)

Buy % Consensus

78
Analysts have set a mean price target of 16.32. This target is 5432.2% above the current price.
CBIO was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CBIO.
In the previous month the buy percentage consensus was at a similar level.
CBIO was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 0.3016.1616.3216.3216.80 - 5,377.97% 5,432.20% 5,432.20% 5,594.92%

Up and Down Grades

Date Firm Action Rating
2021-11-15 Raymond James Downgrade Outperform -> Market Perform
2021-08-06 Raymond James Maintains Outperform
2021-04-29 Raymond James Maintains Outperform
2021-02-10 Piper Sandler Initiate Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA